Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Interpublic Declares Common Stock Dividend and Announces New Share Repurchase Program
-
Gilat Reports Fourth Quarter and Full Year 2024 Results
-
BioCryst Launches ORLADEYO® (berotralstat) in Portugal
-
Orchard Therapeutics Appoints Robin Kenselaar to Chief Commercial Officer and Announces Multiple Business Updates Pertaining to its Approved HSC Gene Therapy for MLD
-
Amplify ETFs to Liquidate Two ETFs
-
Hospitality HQ’s “Gather Food Hall & Bar” to Join Schuylkill Yards at the Bulletin Building
-
Helium Evolution Provides Operations Update on Mankota Helium Fairway
-
Xali Gold Announces Excellent Recoveries from KCA Drill Program at El Oro, Mexico
-
Denny’s Corporation Reports Results for Fourth Quarter and Full Year 2024
-
Boralex: Dividend Declaration
-
A Gift That Matters This Valentine’s Day and Family Day: Drive Sober
-
Halcones Precious Metals Announces Additional Outcrop Chip Channel Sample Results Extending Mineralized Footprint to the South at Polaris Gold Project, Antofagasta Region Chile
-
Aptose’s Frontline Triple Drug Therapy with Tuspetinib Achieves Notable Responses in Newly Diagnosed AML Patients in the Phase 1/2 TUSCANY Trial
-
Standard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025
-
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
-
DMC Global Rejects Non-Binding Proposal from Steel Connect
-
Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck
-
The Chefs’ Warehouse Reports Fourth Quarter 2024 Financial Results
-
OKYO Pharma Announces OK-101 Officially Assigned USAN : Urcosimod
-
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results
-
Oatly Reports Fourth Quarter and Full Year 2024 Financial Results
-
Aligos Therapeutics Announces $105 Million Private Placement Financing
-
QXO Receives Antitrust Clearance for Acquisition of Beacon Roofing Supply
-
PyroGenesis Provides Guidance for Q4 and Full-Year 2024
-
IPG Announces Fourth Quarter and Full Year 2024 Results
-
Lightbridge Successfully Co-Extrudes a Demonstration Coupon Sample with Uranium-Zirconium Alloy and Cladding
-
INmune Bio Opens Phase II in High Dose Cohort of INKmune™ Trial in Prostate Cancer
-
Chicago Atlantic BDC, Inc. Announces the Closing of a New $100 Million Senior Secured Revolving Credit Facility
-
OTC Markets Group Welcomes Wilhelmina International, Inc. to OTCQX
-
OTC Markets Group Welcomes Thiogenesis Therapeutics, Corp. to OTCQX
-
Aquestive Therapeutics to Present New Findings on Anaphylm™ (Epinephrine Sublingual Film) at the 2025 AAAAI Annual Meeting
-
MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers
-
VEON’s JazzCash and Mobilink Bank Shortlisted for Prestigious GLOMO Awards
-
Alm. Brand – Report on trading in Alm. Brand A/S shares by executives and their related parties
-
Release of Marimekko's Financial Statements Bulletin for the year 2024
-
Crown Crafts Announces Third Quarter Fiscal 2025 Financial Results
-
Martin Marietta Reports Fourth-Quarter and Full-Year 2024 Results
-
YieldMax™ ETFs Announces Distributions on SMCY (101.33%), MSTY (100.07%), AIYY (64.15%), YMAX (47.62%), SQY (45.38%) and Others
-
Alpine Income Property Trust Announces Approval of New $10 Million Common Stock Repurchase Program
-
New Publication Highlights Unique Properties of ATI-2138, a Potent and Selective Inhibitor of ITK and JAK3
-
Alliance Witan PLC - Net Asset Value
-
MEXC Unveils February Futures Trading Competition with 8,000,000 USDT Prize Pool
-
Brookfield Asset Management Announces Record 2024 Results and 15% Dividend Increase
-
DT Midstream to Announce Fourth Quarter and Full Year 2024 Financial Results, Schedules Earnings Call
-
Planet 13 Continues to Grow the Iconoclast Universe by Adding Mike Tyson, Ric Flair, and Future
-
Royalty Pharma Announces R&D Funding Collaboration With Biogen
-
Sotherly Hotels Inc. Schedules Fourth Quarter 2024 Earnings Release and Conference Call
-
Hyperscale Data Announces 32 Consecutive Monthly Cash Dividend Payments Timely Paid for Series D Cumulative Redeemable Perpetual Preferred Stock
-
Royalty Pharma Announces R&D Funding Collaboration With Biogen
-
VPG Reports Fiscal 2024 Fourth Quarter and Twelve Months Results

